Adia Nutrition, Inc. ADIA

Q2 FY2026 · ended Jun 30, 2026 · Revenue $485,385, +175.4% YoY · Filed Aug 13, 2026

Adia Nutrition, Inc. (ADIA) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $485,385 and net income of $40,418. Free cash flow was -$109,042. As of Jun 30, 2026 it held $128,115 in cash and investments and $158,465 in total debt.

Revenue
$485,385
+175.4% vs prior quarter
Net income
$40,418
+124.9% vs prior quarter
Operating cash flow
$-109,041
-98.1% vs prior quarter
Free cash flow
$-109,042
-80.1% vs prior quarter
EPS
$0.00
Dividend per share
None
Shares outstanding
94.40M
+0.0% vs prior quarter
Net cash
$-30,350
Q2 FY2026
Operating margin
10.7%
Q2 FY2026

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
ADIA (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Winter Park, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1160420
Former names
Adia Nutrition, Inc. (until Aug 24, 2026); PivX Solutions, Inc. (until Jul 17, 2013); DRILLING INC (until Apr 21, 2004)

Other Medicinal Chemicals & Botanical Products companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Revenue
$485,385
$176,275
Operating income
$51,829
-$151,920
Net income
$40,418
-$162,525
Diluted EPS
$0.00
$0.00
Operating cash flow
-$109,041
-$55,037
Free cash flow
-$109,042
-$60,531
Total assets
$744,054
$776,868
Total liabilities
$1.1M
$1.2M
Stockholders' equity
-$379,781
-$420,199
Cash and investments
$128,115
$136,716
Total debt
$158,465
$178,446

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Oct 19, 2026 Oct 13, 2026
8-K Current report
Agreement ended
Oct 13, 2026 Oct 9, 2026
8-K Current report
Material agreement, Acquisition or sale of assets
Oct 6, 2026 Sep 30, 2026
8-K Current report
Other events
Oct 5, 2026 Sep 28, 2026
8-K Current report
Material agreement
Aug 24, 2026 Aug 19, 2026
8-K Current report
Bylaw or fiscal year change
Aug 17, 2026 Jul 10, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.